FN2 Earnings Intelligence
Albemarle Corporation financials
Albemarle Corporation (ALB) financial statements and key operating metrics from FN2 Research.
Key Stats
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Market Cap | - | - | - | - | - | - | - |
| - Cash | $439.3 | $1,499.1 | $889.9 | $1,192.2 | $1,618 | - | - |
| + Debt | - | - | - | - | - | - | - |
| Enterprise Value | - | - | - | - | - | - | - |
| Revenue | $3,328 | $7,320.1 | $9,617.2 | $5,377.5 | $5,142.7 | $6,403.4 | $6,539.8 |
| % Growth | 6.4% | 120.0% | 31.4% | -44.1% | -4.4% | 24.5% | 2.1% |
| Gross Profit | $998 | $3,074.6 | $1,185.9 | $62.5 | $668.7 | - | - |
| % Margin | 30.0% | 42.0% | 12.3% | 1.2% | 13.0% | - | - |
| EBITDA | $1,052.4 | $2,770.9 | $681.8 | -$1,187.9 | $291.6 | - | - |
| % Margin | 31.6% | 37.9% | 7.1% | -22.1% | 5.7% | - | - |
| Net Income | $123.7 | $2,689.8 | $1,573.5 | -$1,179.4 | -$510.6 | - | - |
| % Margin | 3.7% | 36.7% | 16.4% | -21.9% | -9.9% | - | - |
| Diluted EPS | $1.06 | $22.84 | $13.36 | -$11.20 | -$5.76 | $12.53 | $11.64 |
| % Growth | -69.9% | 2,054.7% | -41.5% | -183.8% | 48.6% | 317.5% | -7.1% |
| Operating Cash Flow | $344.3 | $1,907.8 | $1,325.3 | $702.1 | $1,282.3 | - | - |
| CapEx | $953.7 | $1,261.6 | $2,149.3 | $1,685.8 | $589.8 | - | - |
| Free Cash Flow | -$609.4 | $646.2 | -$824 | -$983.7 | $692.5 | - | - |
Historical market capitalization is not persisted, so Market Cap and Enterprise Value remain unavailable rather than mixing today's market value into prior periods.
Income Statement
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 | 12/31/2026 est. | 12/31/2027 est. |
|---|---|---|---|---|---|---|---|
| Revenue | $3,328 | $7,320.1 | $9,617.2 | $5,377.5 | $5,142.7 | $6,403.4 | $6,539.8 |
| Gross Profit | $998 | $3,074.6 | $1,185.9 | $62.5 | $668.7 | - | - |
| EBITDA | $1,052.4 | $2,770.9 | $681.8 | -$1,187.9 | $291.6 | - | - |
| Net Income | $123.7 | $2,689.8 | $1,573.5 | -$1,179.4 | -$510.6 | - | - |
| Diluted EPS | $1.06 | $22.84 | $13.36 | -$11.20 | -$5.76 | $12.53 | $11.64 |
Balance Sheet
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $439.3 | $1,499.1 | $889.9 | $1,192.2 | $1,618 |
| Short-term Debt | - | - | - | - | - |
| Long-term Debt | $2,004.3 | $3,215 | $3,541 | $3,118.1 | $3,119.5 |
| Total Debt | - | - | - | - | - |
Cash Flow
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | $344.3 | $1,907.8 | $1,325.3 | $702.1 | $1,282.3 |
| Capital Expenditure | $953.7 | $1,261.6 | $2,149.3 | $1,685.8 | $589.8 |
| Free Cash Flow | -$609.4 | $646.2 | -$824 | -$983.7 | $692.5 |
Ratios
USD in millions, except per-share values and percentages.
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2024 | 12/31/2025 |
|---|---|---|---|---|---|
| Revenue Growth | 6.4% | 120.0% | 31.4% | -44.1% | -4.4% |
| Gross Margin | 30.0% | 42.0% | 12.3% | 1.2% | 13.0% |
| EBITDA Margin | 31.6% | 37.9% | 7.1% | -22.1% | 5.7% |
| Net Margin | 3.7% | 36.7% | 16.4% | -21.9% | -9.9% |
| FCF Margin | -18.3% | 8.8% | -8.6% | -18.3% | 13.5% |
| Diluted EPS Growth | -69.9% | 2,054.7% | -41.5% | -183.8% | 48.6% |